DENTSPLY SIRONA Director Clyde Hosein Receives 22,822 RSUs

This Form 4 filing reports that Clyde Hosein, a director of DENTSPLY SIRONA Inc. (XRAY), acquired 22,822 restricted stock units (RSUs) on June 3, 2026. The RSUs were granted at $0 per share and will fully vest one year from the grant date. Following this transaction, Hosein's total holdings in DENTSPLY SIRONA common stock increased to 64,075.456 shares. The filing indicates this is a non-derivative transaction involving equity awards to a company director. The transaction was reported on June 5, 2026, with Jessica Nielsen Causey signing as attorney-in-fact for Clyde Hosein. This type of filing is standard for reporting equity compensation awards to corporate insiders and directors.